Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

A New Approach to Drug Analytics

Posted on December 18th, 2015 by in Pharma R&D

Technological advances in the retrieval and assessment of pathway and bioactivity data are giving rise to new in silico profiling and modeling methods. Continue reading “A New Approach to Drug Analytics” »

Social Media Screening for ADR-monitoring – Like it or not!

Posted on December 16th, 2015 by in Pharmacovigilance

Social Media and Pharmacovigilance

Limitations of clinical trials and traditional post-marketing sources of safety information. 

Due to limitations of pre-marketing clinical trials, there isn’t much information available once a medicinal product is authorized for marketing. Continue reading “Social Media Screening for ADR-monitoring – Like it or not!” »

Are we expecting too much from the EMA’s MLM service?

Posted on December 16th, 2015 by in Pharmacovigilance

ema logo
At the beginning of September 2015, the EMA launched the Medical Literature Monitoring (MLM) service. I recently read the EMA’s MLM launch phase closure report in addition to information from a recent EMA information day and have highlighted some key points below. Continue reading “Are we expecting too much from the EMA’s MLM service?” »

Propelling tomorrow’s chemistry stars

Posted on December 14th, 2015 by in Chemistry

After years of hard work, late nights and hours of toil in the lab, the sought after chemistry PhD can aid young scientists towards a successful career. In such a competitive setting, it’s vital to make sure you stand out as a researcher from the start. Continue reading “Propelling tomorrow’s chemistry stars” »

  1. 1
  2. 2